Skip to Main Content
HBS Home
  • About
  • Academic Programs
  • Alumni
  • Faculty & Research
  • Baker Library
  • Giving
  • Harvard Business Review
  • Initiatives
  • News
  • Recruit
  • Map / Directions
Faculty & Research
  • Faculty
  • Research
  • Featured Topics
  • Academic Units
  • …→
  • Harvard Business School→
  • Faculty & Research→
  • Research
    • Research
    • Publications
    • Global Research Centers
    • Case Development
    • Initiatives & Projects
    • Research Services
    • Seminars & Conferences
    →
  • Publications→

Publications

Publications

Filter Results: (925) Arrow Down
Filter Results: (925) Arrow Down Arrow Up

Show Results For

  • All HBS Web  (925)
    • People  (2)
    • News  (70)
    • Research  (778)
    • Events  (1)
    • Multimedia  (2)
  • Faculty Publications  (667)

Show Results For

  • All HBS Web  (925)
    • People  (2)
    • News  (70)
    • Research  (778)
    • Events  (1)
    • Multimedia  (2)
  • Faculty Publications  (667)
← Page 27 of 925 Results →
  • 04 May 2010
  • First Look

First Look: May 4

We propose that firms' corporate governance and firms' strategic business activities within an industry are interlinked. By conducting a simultaneous economic analysis of business strategy and corporate governance, scholars can better... View Details
Keywords: Martha Lagace
  • 07 Jul 2016
  • Blog Post

Can You Learn Finance through the Case Method?

Greetings from HBS! My name is Siri and I am a second-year student and a candidate for the joint MBA/MPP program between HBS and the Harvard Kennedy School of Government. Before graduate school, I worked for three years as a management consultant specializing in the... View Details
  • 05 Jul 2004
  • Research & Ideas

Radical Change, Entrepreneurial Opportunity

strategies of companies within those industries. In particular, I focus on how an industry gets defined: how consumers and other industry players make sense of, or frame, the industry, and the way that... View Details
Keywords: by Michael J. Roberts; Technology
  • 02 Jul 2001
  • Research & Ideas

Ray A. Goldberg

genome, Goldberg has focused his most recent efforts on explaining the impact of this revolutionary discovery on the agribusiness system. "All industries that deal with living things or organic compounds will have a common language... View Details
Keywords: by Staff; Agriculture & Agribusiness
  • 15 Feb 2000
  • Research & Ideas

The Right Connections

From genome research to e-commerce, new ventures are popping up everywhere, competing for the cash needed to turn them into successful enterprises. But when vying against others in industries where high uncertainty, long development... View Details
Keywords: by Judith A. Ross
  • 12 May 2009
  • First Look

First Look: May 12, 2009

illustrates how deep dives guide the formation of a set of new core activities in the variation-selection-retention process. No PDF is available at this time.   PublicationsWhat Causes Industry Agglomeration? Evidence from Coagglomeration... View Details
Keywords: Martha Lagace
  • 01 Jan 2008
  • News

Jeffrey R. Immelt, MBA 1982

Jeff Immelt’s night table—Railway Age, Aviation Week, Broadcasting & Cable—represents just a few of the industries encompassed by General Electric, the company founded by Thomas Edison where Immelt is entering his ninth year as chairman... View Details
  • Web

Lessons from History - Creating Emerging Markets

watched a short video of Yusuf Hamied discussing the necessity of incremental innovation in the pharmaceuticals industry in the 2000s. Lively discussion then ensued, moderated by HBS Professors Tarun Khanna,... View Details
  • 10 Aug 2020
  • Research & Ideas

COVID's Surprising Toll on Careers of Women Scientists

Foundation. About the Author Rachel Layne is a writer based in the Boston area. [Image: valentinrussanov] Related Reading Restaurant Revolution: How the Industry Is Fighting to Stay Alive Who Guarantees Your Workplace Is Safe for Return?... View Details
Keywords: by Rachel Layne; Pharmaceutical; Pharmaceutical; Pharmaceutical
  • Web

Souvenirs & Novelties - The Art of American Advertising

distribute them and local retailers to print their names on them at no cost. James C. Ayer, involved in the pharmaceutical industry, reaped enormous publicity benefits from the distribution of yearly almanacs. Ayer eventually established... View Details
  • 01 Aug 2001
  • News

Cleveland Global Alumni Conference a Sold-Out Success

& Co., kicked off the first plenary session with a quick overview of factors contributing to the U.S. pharmaceutical industry's success in competing in the global market. Among other ad- vantages, Gilmartin cited the U.S. government's... View Details
Keywords: Hanna, Julia; Frank Batten (MBA '52); Colleges, Universities, and Professional Schools; Educational Services
  • 23 Mar 2010
  • First Look

First Look: March 23

catastrophic risks to patients, physicians, pharmaceutical firms, and regulators. Between the early 1960s and the present, national systems were built to collect, standardize, and respond to individual reports of side effects, with the... View Details
Keywords: Martha Lagace
  • 10 Jun 2008
  • First Look

First Look: June 10, 2008

"Moonshine Shop," a group of plant-savvy creative generalists, is helping a great industrial company become more innovative. Chronicles the history of the Moonshine Shop, its successes and failures, and describes innovations... View Details
Keywords: Martha Lagace
  • 26 Jun 2000
  • Research & Ideas

What’s an Internet Business Model? Ask a Health Care Professional

will be done," Applegate said. "That ability to play above and below the line is fundamental to success because it provides revenue streams. There is nothing stickier than getting everyone in your industry to do business on your... View Details
Keywords: by Martha Lagace; Health
  • 19 Aug 2002
  • Research & Ideas

Here Comes Internet2—Time to Shed Dot Vertigo

The same DVD would take approximately twenty-five hours to download via a standard DSL/cable line (and 170 hours—or more than seven days—via a 56K modem). Genomics and pharmaceuticals are other research arenas that should benefit from the... View Details
Keywords: by Martha Lagace
  • 18 Aug 2017
  • Op-Ed

Op-Ed: Courageous Leader Triggers a Moral Revolt of CEOs Against Trump

actions was not without risk for the CEOs and their companies” While many CEOs prefer to stay under the radar and avoid public scrutiny, Ken Frazier led the way with his example. As the chair of PhRMA, the pharmaceutical manufacturers... View Details
Keywords: by Bill George
  • 2000
  • Chapter

Millennium Pharmaceuticals, Inc.

By: S. Thomke and A. Nimgade
Keywords: Pharmaceutical Industry
Citation
Related
Thomke, S., and A. Nimgade. "Millennium Pharmaceuticals, Inc." In Inside Biotechnology and Pharmaceuticals.Harvard Business School From the Field Series. Boston, MA: Harvard Business School Publishing, 2000.
  • 1996
  • Chapter

Eli Lilly and Company: Drug Development Strategy

By: S. Thomke, A. Nimgade and P. Pospisil
Keywords: Product Development; Corporate Strategy; Pharmaceutical Industry
Citation
Related
Thomke, S., A. Nimgade, and P. Pospisil. "Eli Lilly and Company: Drug Development Strategy." In Strategic Management of Technology and Innovation. 2nd ed. by R. Burgelman, M. A. Maidique, and S. C. Wheelwright. Burr Ridge, IL: Irwin/McGraw-Hill, 1996.
  • January 1994
  • Case

Evolving Finance Function: Judy C. Lewent at Merck & Co., Inc.

By: Timothy A. Luehrman
This case examines the career path of Merck's CFO, Judy C. Lewent, as a way of tracing changes over time in Merck's finance function. It describes the adoption of innovative quantitative analytical models, changes in job definitions and in the organization of the... View Details
Keywords: Finance; Mathematical Methods; Personal Development and Career; Organizational Design; Innovation and Invention; Pharmaceutical Industry
Citation
Educators
Purchase
Related
Luehrman, Timothy A. "Evolving Finance Function: Judy C. Lewent at Merck & Co., Inc." Harvard Business School Case 294-014, January 1994.
  • January 2025 (Revised March 2025)
  • Case

Gavi and the 'Next' Pandemic

By: Tarun Khanna and Kerry Herman
In 2025, CEO Dr. Sania Nishtar and her team consider the lessons the Global Alliance for Vaccine and Immunizations (GAVI) learned from the pandemic. GAVI successfully brought COVID-19 vaccines to large swaths of the undeveloped and under-developed world by pooling... View Details
Keywords: Developing Countries and Economies; Health Care and Treatment; Health Pandemics; Crisis Management; Success; Innovation and Invention; Service Delivery; Organizational Change and Adaptation; Strategic Planning; Pharmaceutical Industry; Africa
Citation
Educators
Purchase
Related
Khanna, Tarun, and Kerry Herman. "Gavi and the 'Next' Pandemic." Harvard Business School Case 725-351, January 2025. (Revised March 2025.)
  • ←
  • 27
  • 28
  • …
  • 46
  • 47
  • →
ǁ
Campus Map
Harvard Business School
Soldiers Field
Boston, MA 02163
→Map & Directions
→More Contact Information
  • Make a Gift
  • Site Map
  • Jobs
  • Harvard University
  • Trademarks
  • Policies
  • Accessibility
  • Digital Accessibility
Copyright © President & Fellows of Harvard College.